Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Busch

Showing results (661-670 of 678) with videos related to

Pageof 68
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2020
Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohortMarieke S Walma, Lilly J Brada, Susana I S Patuleia, et al.
JAMA Surgery|February 14, 2024
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical TrialTara M Mackay, Anouk E J Latenstein, Simone Augustinus, et al.
Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.
Lancet (London, England)|May 1, 2022
Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trialF Jasmijn Smits, Anne Claire Henry, Marc G Besselink, et al.
JAMA Network Open|March 31, 2026
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical TrialLeonard W F Seelen, Lilly J H Brada, Marieke S Walma, et al.
The Lancet. Oncology|September 13, 2025
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trialQuisette P Janssen, Jacob L van Dam, Marlies L van Bekkum, et al.
Annals of Surgery|March 5, 2019
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome ComparisonsPatricia Sánchez-Velázquez, Xavier Muller, Giuseppe Malleo, et al.
International Journal of Cancer|June 26, 2024
Potential association between PSCA rs2976395 functional variant and pancreatic cancer riskChiara Corradi, Giulia Lencioni, Alessio Felici, et al.
Annals of Surgery|November 4, 2017
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched StudyJony van Hilst, Thijs de Rooij, Sjors Klompmaker, et al.
The British Journal of Surgery|December 1, 2025
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and -2 trialsBo T M Strijbos, Imme Kraakman, Jana S Hopstaken, et al.
Pageof 68

Showing results (661-670 of 678) with videos related to

Sort By:
Pageof 68
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2020
Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohortMarieke S Walma, Lilly J Brada, Susana I S Patuleia, et al.
JAMA Surgery|February 14, 2024
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical TrialTara M Mackay, Anouk E J Latenstein, Simone Augustinus, et al.
Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.
Lancet (London, England)|May 1, 2022
Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trialF Jasmijn Smits, Anne Claire Henry, Marc G Besselink, et al.
JAMA Network Open|March 31, 2026
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical TrialLeonard W F Seelen, Lilly J H Brada, Marieke S Walma, et al.
The Lancet. Oncology|September 13, 2025
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trialQuisette P Janssen, Jacob L van Dam, Marlies L van Bekkum, et al.
Annals of Surgery|March 5, 2019
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome ComparisonsPatricia Sánchez-Velázquez, Xavier Muller, Giuseppe Malleo, et al.
International Journal of Cancer|June 26, 2024
Potential association between PSCA rs2976395 functional variant and pancreatic cancer riskChiara Corradi, Giulia Lencioni, Alessio Felici, et al.
Annals of Surgery|November 4, 2017
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched StudyJony van Hilst, Thijs de Rooij, Sjors Klompmaker, et al.
The British Journal of Surgery|December 1, 2025
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and -2 trialsBo T M Strijbos, Imme Kraakman, Jana S Hopstaken, et al.
Pageof 68